CIP2A and leukemia: Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a recently identified oncoprotein that is overexpressed in several malignancies, including leukemia, breast, gastric, prostate, lung, ovarian, head and neck carcinoma, and colorectal cancer [6-21].